PI3K/AKT is the most frequently mutated pathways in cancer, and most of the p85αPI3K mutations cluster in the inter-SH2 (iSH2) domain of the molecule, which interacts with the catalytic subunit p110αPI3K [92]. Here, AKT1 is linked to cancer.